Skip to contentA
Ardent Health, Inc.
A
ARDTArdent Health, Inc. Q2 2026 · 10-Q
Revenue$1.62B$1.62B−1.4% vs Q2 2025 Net Income$16.90M$16.90M−76.8% vs Q2 2025 EPS Diluted$0.12$0.12−76.9% vs Q2 2025 Operating Cash Flowderived$196,735,000+67.4% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ardent Health, Inc. · CIK 1756655 · Engraved from SEC EDGAR
Margins · derivedNet margin1.0%−3.4 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 10, 2026 · 41 d after period end